Pfizer Inc. (PFE), a pharmaceutical and biotechnology company, on Tuesday revised its annual revenue expectations below Street view. However, the company reaffirmed adjusted earnings outlook. In addition, Pfizer initiated outlook for fiscal 2026.
For fiscal 2025, the drug maker has reaffirmed adjusted earnings outlook of $3 to $3.15 per share. On average, 24 analysts polled forecast the company to earn $3.13 per share for the year. Analysts' estimates typically exclude special items.
Pfizer now projects revenue of around $62 billion, compared with the earlier outlook of $61 billion to $64 billion. Analysts, on average, forecast the company to register revenue of $62.52 billion for the year.
For fiscal 2026, the company anticipates earnings of $2.80 to $3 per share, below Street view of $3.06 per share. Pfizer projects revenue of $59.5 billion to $62.5 billion, in line with analysts' forecast of $61.68 billion.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.